Skip to content
Search

Latest Stories

New Covid-19 vaccination centre opens in Leicester with Patels Chemist

Patels Chemist, part of the Morningside Pharmacy group, has started high-volume NHS Covid-19 vaccination facility at the Jalaram Community Centre in Leicester today (October 12).

The new vaccination site, having an administering capacity of up to 3,000 vaccinations a week, will serve the local community in Leicester, especially in the Westcotes area.


The move is part of the government’s Covid-19 booster programme which started last month and has since seen millions of the UK’s most vulnerable being offered the jab.

As per government guideline, the centre will first offer vaccines to the priority group that includes care home residents, health and social care workers, people aged over 50, those aged 16 to 49 years with underlying health conditions, adult carers, and adult household contacts of immunosuppressed individuals.

Jala 2

Pramod Thakkar, chairman of the Jalaram Charitable Trust, said: “The Jalaram Community Centre has always been used for various multi-cultural activities for various faiths to come together and has been an integral part of Leicester’s multicultural success.

He added that hosting the Covid-19 vaccination fits perfectly into the ethos and values of the trust.

Danesh Gadhia, CEO Morningside group of pharmacies, said: “Patels Chemist on Narborough Road has been caring for the health of our local community for over 30 years and we are extremely proud to be part of the national NHS effort against the Coronavirus pandemic.

“We know that one of the ways to overcome Covid-19 vaccine hesitancy among ethnic minority groups is through local engagement and trust.

“This combination (Patels Chemist and the Jalaram Temple) we hope will encourage people to come forward for the vaccination and help us beat this pandemic.”

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less